SARS-CoV-2 Mpro-IN-39
SARS-CoV-2 Mpro-IN-39 (Compound 9d) is an inhibitor of the main protease (Mpro) of SARS-CoV-2, with an IC50 value of 5.94 µM, an EC50 value of 9.33 µM for inhibiting the replication of SARS-CoV-2 in Vero cells, and a cytotoxicity CC50 value of 289.63 µM. SARS-CoV-2 Mpro-IN-39 can be used in the research of the anti-COVID-19 field[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV; Virus Protease
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
CC1=C(/C=C/C2=CC=CC=C2[N+]([O-])=O)SC(N/N=C3CCCCC4=C\3C=CC=C4)=N1
Molecular Formula
C23H22N4O2S
Molecular Weight
418.51
References & Citations
[1]Farghaly TA, et al. Novel Benzosuberone/Indanone-Linked Thiazoles as Small-Molecule SARS-CoV-2 Main Protease Inhibitors. Drug Dev Res. 2025 Apr;86 (2) :e70081.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC942609-500 1x 500 µL
NRF1 (NRF1/2609), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
E-EL-M1233-01 24 Tests
Mouse VCAM-1/CD106 (Vascular cell adhesion molecule 1) ELISA Kit
Sign In for Pricing
View Details